In this podcast, Daniel M. Musher, MD, answers our questions on his systematic review of the etiology of community-acquired pneumonia and briefly discusses his extensive research on community-acquired...
In this podcast, Chuck Vega, MD, speaks about how clinicians determine site and duration of treatment for community-acquired bacterial pneumonia (CABP) based on patients' factors and prior treatment,...
Forest Arnold, MD, and Michael Egger, MD, speak about their study that aimed to evaluate the cost-effectiveness of adhering to treatment guidelines for community-acquired bacterial pneumonia in elderly...
